decemb
march
case
death
worldwid
identifi
caus
newli
identifi
envelop
rnaviru
name
unit
kingdom
januari
march
case
identifi
test
patient
death
due
widespread
natur
declar
pandem
world
health
organ
march
countri
affect
march
sar
pandem
report
affect
pediatr
adult
kidney
transplant
recipi
hong
kong
less
sever
diseas
pediatr
popul
one
liver
transplant
patient
die
sarscov
infect
mer
coronaviru
infect
variabl
impact
kidney
transplant
recipi
report
kidney
transplant
patient
one
die
progress
respiratori
diseas
acut
kidney
injuri
surviv
best
knowledg
patient
kidney
transplant
report
literatur
suffer
infect
wuhan
china
improv
day
hospit
admiss
kidney
transplant
recipi
present
fever
chest
pain
cough
low
lymphocyt
high
serum
creactiv
protein
crp
abnorm
chest
comput
tomographi
scan
februari
tacrolimu
mycophenol
administr
discontinu
treat
oxygen
methyl
prednisolon
umifenovir
moxifloxacin
biapenem
iv
ig
inhal
interferona
pantoprazol
made
success
recoveri
discharg
day
report
first
case
kidney
transplant
recipi
south
london
hospit
seen
case
kidney
transplant
recipi
proven
infect
south
london
march
patient
describ
herein
main
characterist
summar
tabl
prednisolon
mg
od
chang
angiotensinconvert
enzym
inhibitorangiotensin
receptor
blocker
time
present
made
full
recoveri
transplant
kidney
function
remain
stabl
woman
insulindepend
type
diabet
endstag
kidney
diseas
hemodialysi
therapi
year
receiv
deceas
donor
kidney
transplant
march
egfr
mlmin
per
maintain
tacrolimu
level
ngml
mycophenol
mofetil
mmf
mg
twice
day
bd
prednisolon
mg
od
medic
includ
ramipril
aspirin
alfacalcidol
amilorid
present
march
cough
fever
short
breath
chest
xray
reveal
bilater
patchi
consolid
figur
rna
polymeras
chain
reaction
test
nose
throat
viral
swab
posit
bronchial
wash
pneumocysti
polymeras
chain
reaction
neg
blood
polymeras
chain
reaction
cytomegaloviru
dna
posit
microbiolog
diagnosi
hypox
peripher
oxygen
satur
respiratori
rate
breath
min
transfer
intens
therapi
unit
itu
commenc
noninvas
ventil
continu
posit
airway
pressur
type
respiratori
failur
subsequ
intub
ventil
clinic
condit
deterior
serum
crp
admiss
mgl
hemoglobin
gl
normal
total
white
cell
count
mild
lymphopenia
lymphocyt
count
l
treat
broad
spectrum
antibiot
specif
antivir
drug
given
mmf
ceas
lowdos
tacrolimu
initi
continu
stop
day
death
day
post
admiss
develop
acut
kidney
injuri
aki
serum
creatinin
increas
mmoll
remain
stabl
ventil
reduc
oxygen
requir
improv
lung
infiltr
chest
xray
figur
deterior
markedli
march
high
serum
lactat
lactat
dehydrogenas
level
acut
rise
crp
develop
sever
metabol
acidosi
resist
correct
continu
venoven
hemodiafiltr
probabl
owe
intraabdomin
event
bowel
infarct
andor
intraabdomin
sepsi
deterior
rapidli
die
march
trimoxazol
mg
doxazosin
mg
isoniazid
mg
omeprazol
mg
pyridoxin
mg
gliclazid
mg
mg
three
month
deceas
donor
kidney
transplant
march
present
short
breath
emerg
depart
initi
assess
oxygen
satur
heart
rate
beat
min
blood
pressur
mm
hg
start
immedi
continu
posit
airway
pressur
oxygen
satur
improv
auscult
chest
reveal
widespread
crepit
chest
xray
show
bilater
pulmonari
infiltr
supplementari
figur
found
posit
rna
cytomegaloviru
adenoviru
respiratori
viral
screen
along
atyp
pneumonia
serolog
neg
posit
microbiolog
diagnosi
develop
featur
acut
respiratori
distress
syndrom
aki
creatinin
mmoll
baselin
mmoll
respiratori
statu
rapidli
deterior
emerg
depart
requir
intub
hour
later
continu
ventil
current
mmf
stop
march
tacrolimu
march
broad
spectrum
antibiot
antivir
oseltamivir
administ
also
empir
treat
pneumocysti
high
dose
cotrimoxazol
serum
crp
decreas
mgl
day
admiss
mgl
day
later
becam
anur
start
continu
venoven
hemofiltr
continu
latest
chest
xray
show
resolut
pulmonari
infiltr
supplementari
figur
wheelchairbound
man
histori
hypertens
nephrosclerosi
recurr
thromboembol
event
develop
endstag
renal
diseas
receiv
deceas
donor
kidney
transplant
august
seventeen
month
kidney
transplant
present
hospit
short
breath
chest
pain
admit
itu
diagnos
infect
march
mmf
stop
current
continu
tacrolimu
prednisolon
discharg
itu
current
admit
medic
ward
still
requir
l
oxygen
maintain
satur
kidney
function
remain
stabl
woman
longstand
diabet
hypertens
endstag
kidney
diseas
periton
dialysi
therapi
sinc
hemodialysi
therapi
sinc
receiv
deceas
donor
kidney
transplant
februari
discharg
march
immunosuppress
treatment
includ
tacrolimu
mmf
prednisolon
medic
includ
insulin
amlodipin
mg
ezetimib
mg
levothyroxin
mg
cotrimoxazol
mg
well
doxazosin
mg
bd
clonazepam
mg
need
present
short
breath
fever
c
diarrhea
vomit
march
chest
xray
show
shadow
left
base
march
worsen
march
supplementari
figur
b
test
posit
rna
march
unwel
oxygen
satur
blood
pressur
mm
hg
oxygen
satur
improv
l
oxygen
nasal
cannula
hemoglobin
gl
serum
ntermin
prohormon
brain
natriuret
peptid
ngl
serum
fibrinogen
gl
lymphocyt
count
decreas
day
admiss
l
remain
low
tacrolimu
continu
mmf
held
march
treat
initi
doxycyclin
piperacillintazobactam
paracetamol
furosemid
blood
transfus
move
itu
march
respiratori
support
need
lmin
oxygen
transfer
back
ward
march
march
serum
creatinin
mmoll
remain
inpati
manag
gener
ward
man
urat
nephropathi
past
histori
hereditari
hemolyt
anemia
receiv
kidney
transplant
year
ago
present
march
cough
fever
c
test
posit
rna
march
adequ
hydrat
vital
stabl
receiv
paracetamol
continu
usual
medic
includ
advagraf
tabl
remain
symptomat
march
cough
mild
fever
symptom
resolv
mmf
stop
manag
stay
home
man
fail
second
kidney
transplant
septemb
present
fever
flulik
symptom
cough
day
short
breath
day
arteri
hypertens
comorbid
sensit
recipi
panel
reactiv
antibodi
therefor
maintain
longterm
tripl
immunosuppress
tacrolimu
azathioprin
switch
late
mmf
due
gastrointestin
side
effect
prednisolon
mg
od
admiss
march
tachypn
hypox
oxygen
satur
room
air
correct
l
min
oxygen
nasal
cannula
nasal
throat
swab
posit
rna
develop
aki
serum
creatinin
mmoll
egfr
mlmin
per
baselin
creatinin
baselin
egfr
lymphopen
lymphocyt
count
l
baselin
l
normal
hemoglobin
white
cell
count
liver
function
test
normal
admiss
alanin
aminotransferas
went
ul
day
chest
xray
reveal
bilater
infiltr
supplementari
figur
azathioprin
stop
admiss
tacrolimu
reduc
prednisolon
increas
mg
od
far
need
hemodialysi
session
recov
respiratori
point
view
march
oxygen
satur
lmin
remain
hemodynam
stabl
report
discuss
first
case
infect
kidney
transplant
recipi
south
london
unit
kingdom
median
age
transplant
recipi
year
rang
year
compris
men
women
patient
manag
outpati
basi
stay
home
remain
requir
hospit
admiss
four
among
latter
requir
itu
admiss
manag
renal
ward
patient
sent
itu
need
intub
ventil
manag
oxygen
mask
noninvas
ventil
death
small
seri
patient
mortal
rate
patient
sever
diseas
femal
also
diabet
two
patient
present
within
month
kidney
transplant
within
week
kidney
transplant
vintag
month
remain
case
patient
manag
center
total
number
preval
transplant
patient
center
patient
transplant
decemb
march
develop
pandem
transplant
patient
higher
risk
due
immunosuppress
underli
chronic
kidney
diseas
comorbid
particular
diabet
hypertens
recogn
signific
factor
influenc
outcom
patient
infect
three
patient
chronic
kidney
diseas
stage
recov
home
requir
hospit
admiss
recov
without
need
itu
admiss
remain
patient
chronic
kidney
diseas
stage
sever
diseas
requir
intub
ventil
die
patient
sever
includ
one
die
diabet
mellitu
manag
immunosuppress
patient
challeng
take
account
age
sever
infect
associ
comorbid
time
posttranspl
transplant
patient
mild
moder
infect
usual
practic
continu
make
reduct
dose
immunosuppress
drug
approach
might
favor
high
mortal
patient
admit
hospit
infect
acknowledg
firm
recommend
possibl
base
small
sampl
size
studi
suggest
antiprolif
agent
mmf
azathioprin
stop
time
admiss
hospit
dose
prednisolon
either
unchang
increas
tacrolimu
dose
reduc
sever
infect
requir
intub
ventil
argument
made
stop
calcineurin
inhibitor
complet
maintain
corticosteroid
therapi
role
cytokin
storm
inflamm
due
antivir
immun
respons
driver
sever
respiratori
diseas
acut
respiratori
distress
syndrom
discuss
sinc
outbreak
diseas
decemb
prompt
trial
antiinterleukin
monoclon
antibodi
tocilizumab
case
continu
steroid
infect
patient
similar
argument
made
continu
lowdos
tacrolimu
evid
need
draw
firm
conclus
obviou
concern
risk
reject
reduct
immunosuppress
given
high
mortal
rate
infect
hospit
patient
clinician
focu
keep
patient
aliv
care
casebycas
assess
risk
versu
benefit
continu
immunosuppress
regard
induct
treatment
like
lymphocytedeplet
antibodi
increas
risk
therefor
mani
center
unit
kingdom
stop
perform
transplant
requir
induct
either
antithymocyt
globulin
alemtuzumab
patient
seri
receiv
basiliximab
induct
therapi
time
transplant
five
patient
present
receiv
tripl
immunosuppress
two
patient
mild
ill
requir
hospit
admiss
recov
fulli
home
dual
immunosuppress
azathioprin
plu
prednisolon
tacrolimu
plu
mmf
regard
concomit
therapi
angiotensinconvert
enzym
inhibitor
angiotensin
receptor
blocker
line
current
uk
renal
associ
european
societi
cardiolog
recommend
therapi
discontinu
one
patient
die
mortal
rate
although
soon
comment
like
mortal
rate
group
patient
two
patient
present
within
month
transplant
present
within
week
uk
nation
health
servic
blood
transplant
organ
donat
transplant
sinc
produc
guidelin
screen
deceas
donor
transplant
unit
risk
stratifi
donor
recipi
consid
kidney
transplant
transplant
highrisk
procedur
pandem
due
risk
transmit
infect
donor
recipi
well
risk
recipi
develop
sever
diseas
higher
level
immunosuppress
first
month
posttranspl
suggest
apart
care
select
donorrecipi
pair
transplant
advis
pandem
especi
older
recipi
comorbid
particular
diabet
stop
perform
live
donor
transplant
discuss
suspend
deceas
donor
program
addit
signific
concern
effect
immunosuppress
patient
increas
worri
access
itu
come
week
redistribut
staff
critic
care
provid
support
increas
number
patient
like
deceas
donor
program
suspend
within
uk
center
soon
aki
describ
infect
patient
occurr
proteinuria
hematuria
report
seri
observ
patient
aki
may
earli
signal
transplant
patient
higher
risk
aki
infect
compar
aki
critic
ill
patient
gener
popul
wuhan
china
angiotensinconvert
enzym
dipeptidyl
peptidas
express
proxim
tubul
cell
identifi
receptor
sarscov
merscov
uptak
viru
proxim
tubular
epithelium
possibl
explan
aki
regard
prognost
blood
test
includ
lymphocyt
count
serum
level
dimer
ferritin
troponin
like
valuabl
four
patient
requir
admiss
lymphopenia
wherea
need
admiss
normal
lymphocyt
count
mani
patient
immunosuppress
like
baselin
lymphopenia
drop
lymphocyt
count
like
prognost
valu
patient
die
dimer
troponin
level
elev
day
post
admiss
mark
increas
particular
dimer
later
cours
ill
absenc
obviou
thromboembol
event
suggest
microvascular
thrombosi
dissemin
intravascular
coagul
possibl
gut
ischemia
high
ferritin
dimer
level
also
note
case
patient
seri
suggest
dimer
ferritin
troponin
measur
patient
sever
infect
admiss
subsequ
show
clinic
improv
patient
lung
infiltr
show
signific
improv
without
specif
antivir
treatment
day
post
admiss
patient
die
among
improv
respiratori
point
view
die
abdomin
complic
clinic
diagnosi
possibl
bowel
infarct
intraabdomin
sepsi
base
observ
would
like
highlight
mortal
critic
ill
patient
infect
could
due
extrapulmonari
complic
myocard
bowel
involv
regard
specif
antivir
therapi
although
recent
trial
show
benefit
lopinavirritonavir
hospit
patient
sever
remain
possibl
treatment
drug
well
hydroxychloroquin
consid
patient
pneumonia
choic
calcineurin
inhibitor
may
also
role
play
thu
instanc
cyclosporin
shown
inhibitori
effect
prolifer
corona
virus
hepat
c
viru
vitro
case
tacrolimu
cyclosporin
thought
inhibit
replic
divers
array
coronavirus
impact
cyclophilin
b
need
explor
think
switch
cyclosporin
tacrolimu
recommend
stage
transplant
patient
infect
conclus
first
seri
renal
transplant
patient
infect
recipi
die
signific
aki
observ
lymphopenia
high
ferritin
dimer
level
rais
troponin
level
seen
sever
diseas
may
prognost
valu
test
part
routin
test
kidney
transplant
patient
requir
hospit
admiss
infect
suggest
suspend
kidney
transplant
pandem
particularli
highrisk
older
recipi
comorbid
rigor
adher
hand
hygien
recommend
isol
procedur
regular
assessmentvirtu
andor
telephonicallyof
transplant
patient
help
reduc
incid
facilit
manag
mildtomoder
case
commun
could
patient
describ
uk
regist
set
uk
transplant
registri
held
organ
donat
transplant
record
case
renal
transplant
patient
present
infect
analysi
registri
data
help
clinician
make
inform
decis
manag
complex
patient
uncertain
rapidli
evolv
time
